FDA D.I.S.C.O.: A new drug approval for non-metastatic castration-resistant prostate cancer

Share:

Listens: 0

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

Science

FDA D.I.S.C.O.: A new drug approval for non-metastatic castration-resistant prostate cancer